Announcement on Convening the 2025 Annual Performance Briefing
Filed with SSE · · 2 pages · Chinese
Earlier from InventisBio
- Announcement on Termination of the 2025 Restricted Stock Incentive Plan
- Announcement on Voluntary Disclosure of the Completion of Full Subject Enrollment in the Phase III Clinical Trial of D-2570 for Psoriasis
- Announcement on Voluntary Disclosure of D-2570 Receiving Approval to Conduct Phase II Psoriasis Clinical Trial in the United States
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Cancellation of Some Proposals at the 1st Extraordinary General Meeting in 2026
Later from InventisBio
- Announcement on Achievements of Vesting Conditions in the 3rd Vesting Period of Those Initially Granted (2nd Batch) and the 2nd Vesting Period of Those Reserved for Grant in 2022 Restricted Stock Incentive Plan
- Report for Q1 2026
- Announcement on Resolutions of the 6th Meeting of the 2nd Board of Directors in 2026
- Announcement on Vesting Results of the 3rd Vesting Period of Those Initially Granted and the 2nd Vesting Period of Those Reserved for Grant (2nd Batch) in 2022 Restricted Stock Incentive Plan and Listing of Shares
- Publicity Explanation and Verification Opinions of Remuneration and Appraisal Committee of Board of Directors on List of Incentive Objects in 2026 Restricted Stock Incentive Plan
Follow InventisBio into a list and get an email when it puts out news.
Follow InventisBio